Navigation Links
January American Naturalist highlights
Date:1/4/2008

only slightly different assumptions have come to wildly different conclusions, making it hard to generalize results and leading to fierce debate.

In a recent study published in The American Naturalist, Pleuni Pennings and her coworkers chose a different approach. They started out from a widely cited simulation model by Ulf Dieckmann and Michael Doebeli, who investigated sympatric speciation driven by resource competition. They then simplified the assumptions of this model to make it mathematically tractable. While retaining each of the crucial ingredients, Pennings et al. managed a completely analytical dissection of the model, something that had not appeared possible beforehand. They found that varying the model parameters produced phenomena that had previously been described in separate papers. "This means that our model unifies insights from earlier work, which is very rewarding," says Michael Kopp, one of the authors of the study. "We also gained a better understanding of the underlying mechanisms, such as the interplay of natural and sexual selection."


"Plants may alter competition by modifying nutrient bioavailability in rhizosphere: a modeling approach"
Xavier Raynaud (Universit Paris-Sud and Universit Pierre et Marie Curie-Paris), Benot Jaillard (Laboratoire de Biogochimie du Sol et de la Rhizosphre), and Paul W. Leadley (Universit Paris-Sud)

Plants need nutrients such as Nitrogen and Phosphorus from the soil to grow. In temperate grasslands, several plant individuals can often be found on a small surface with their roots system thoroughly entwined. How plants share soil nutrients in these ecosystems has been the subject of debate between ecologists for decades, with several key questions still unanswered. In particular, few theories of plant competition account for the well-documented ability of plants to increase the availability of key soil nutrients by releasing protons or organic compounds from their roo
'/>"/>

Contact: Rudy Faust
rfaust@press.uchicago.edu
773-834-0386
University of Chicago Press Journals
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008
2. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
3. January is National Glaucoma Awareness Month
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008
6. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
7. National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month
8. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
9. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
10. Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
11. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...tiretroviral therapy may be due to genetic factors... A new study challenges the long-held belief that ...tem,s ability to restore itself after HIV patients...rapy (HAART). , From 50 percent to 90 percent o...CV. Intravenous drug use is the main cause of both...
(Date:7/25/2008)...ng overweight or obese is not only a personal issu...ealth issue that impacts other people in society. ...ch reveals that the extra Medicare cost associate...nificant financial burden on tax payers, costing u...tire current Medicare population. , The article...
(Date:7/25/2008)... consumers tips and encourages them to, ,Speak Up...., July 25 /PRNewswire-USNewswire/ -- The Pennsylv...onal Patient Safety Day" which,is a national effor...icipate fully in their healthcare by asking questi...urgery or illness., "We understand the important ...
(Date:7/25/2008)...the number of jobs created in the medical field sl...different kind of slowdown: they laid off fewer pe... Seattle, WA (PRWEB) July 25, 2008 -... field slowed in June overall, pharmaceutical comp...ill be music to the ears of sales representatives:...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3
...ted by the type 3 virus which spreads by bugs and ...t most of the winegrowers have bought the national...free from the virus. New Zealand Winegrowers scien...said that a lot of research is being done to under...
... Journal of the National Cancer Institute, childho...premature menopause//. Ovarian irradiation and ce...ost common risk factors associated with early meno...hildren or adolescents diagnosed with cancer will ...
...MA) has issued a warning that the nation could be ... future due to a lack of clinical expertise. Dr M...the federal MPs and senators insisting for a strat... deal with the increase in number of students. He ...
...that inhabitants of Phet where hundreds of poultry...since they had a feast on these birds. Public hea...ichit are trying to create awareness of bird flu a...usly here. Dr. Prachak Wattanakun, a provincial he...
Other Medicine News:
(Date:7/24/2008)...W, Calif., July 24 /- Alexz... today that it has initiated,its second Phase 3 cl...Z-004 is an inhalation product candidate being dev...ients with schizophrenia or bipolar disorder.,Alex...id pharmacokinetic,(PK) properties resulting from ...
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Headlines claim...he whole story. The small scale,preliminary study...n,Reproduction, is based on recollected intake of ...oods. "This study is confounded by many,issues, th...t deal of,caution," warned Dr. Tammy Hedlund, a re...
(Date:7/24/2008)...y thermometer designed to take body temperature, f...-- Kidz-Med, Inc.,(subsidia...ts: ASFX),United States distributor of the Thermo...d to announce the results of a clinical study,cond...rsity of Milan, in,Milan, Italy, which proves that...
(Date:7/24/2008)...OLIS, France, July 24 /- Ni... top-line results from the 52-week,open label safe...letion of,the 301 phase 3 study for naproxcinod. T...and efficacy was maintained for the one-year durat...bal assessment scale. In,addition, the results sho...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Mylan Restores Availability of Generic Levothyroxine in Florida 11381 1Mylan Restores Availability of Generic Levothyroxine in Florida 11381 2Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 1Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 2Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 3Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 4Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 5Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 6Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 7Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 8Chindex International Inc Announces Results for the Quarter and Nine Months Ended December 31 2007 11378 9Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 1Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 3Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 4Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 5Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 6Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 7Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 8Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 9Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 10Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 11Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 12Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 13Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 14Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 15Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 16Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 17Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 18Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 19Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 20Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 21Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 22Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 23Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 24Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 25Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 26Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 27Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 28Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 29Roche Purchases Shares in Tender Offer for Ventana 11373 1Roche Purchases Shares in Tender Offer for Ventana 11373 2Roche Purchases Shares in Tender Offer for Ventana 11373 3Roche Purchases Shares in Tender Offer for Ventana 11373 4
... Breakthrough Will Aid in Developing Therapies to ... EMERYVILLE, Calif., May 10, 2007 /PRNewswire/ -- ...development company, announced,today the first met...issues in animals through the pathway known as rev...known mechanism by which excess,cholesterol can be...
...taly--(BUSINESS WIRE)--May 14, 2007 - Acceleron Ph... therapeutics for the,treatment of musculoskeletal...ounced results of a preclinical study with,ACE-031...increase,muscle mass and strength in normal mice a... inhibits negative regulators of muscle,to increas...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens
ZyDoc offers a full medical transcription and documentation solution.
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
Medicine Products: